| Expanded and independent validation of the movement disorder society–unified Parkinson’s disease rating scale (MDS-UPDRS) P Martinez-Martin, C Rodriguez-Blazquez, M Alvarez-Sanchez, T Arakaki, ... Journal of neurology 260, 228-236, 2013 | 261 | 2013 |
| Assessing the non‐motor symptoms of Parkinson's disease: MDS‐UPDRS and NMS Scale P Martinez‐Martin, KR Chaudhuri, JM Rojo‐Abuin, ... European Journal of Neurology 22 (1), 37-43, 2015 | 151 | 2015 |
| Differences in MDS‐UPDRS scores based on Hoehn and Yahr stage and disease duration M Skorvanek, P Martinez‐Martin, N Kovacs, M Rodriguez‐Violante, ... Movement disorders clinical practice 4 (4), 536-544, 2017 | 119 | 2017 |
| The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease C Rodriguez-Blazquez, JM Rojo-Abuin, M Alvarez-Sanchez, T Arakaki, ... Parkinsonism & related disorders 19 (10), 889-893, 2013 | 85 | 2013 |
| Relationship between the MDS‐UPDRS domains and the health‐related quality of life of P arkinson's disease patients P Martínez‐Martín, C Rodríguez‐Blázquez, MJ Forjaz, ... European Journal of Neurology 21 (3), 519-524, 2014 | 76 | 2014 |
| Relationship between the MDS-UPDRS and quality of life: a large multicenter study of 3206 patients M Skorvanek, P Martinez-Martin, N Kovacs, I Zezula, ... Parkinsonism & related disorders 52, 83-89, 2018 | 72 | 2018 |
| Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: a review of the current clinical evidence S Bette, DS Shpiner, C Singer, H Moore Therapeutics and clinical risk management, 1737-1745, 2018 | 55 | 2018 |
| Insomnia, sleep quality, and quality of life in mild to moderate Parkinson’s disease S Shafazand, DM Wallace, KL Arheart, S Vargas, CC Luca, H Moore, ... Annals of the American Thoracic Society 14 (3), 412-419, 2017 | 42 | 2017 |
| Gender disparities in deep brain stimulation for Parkinson's disease DS Shpiner, DG Di Luca, I Cajigas, JS Diaz, J Margolesky, H Moore, ... Neuromodulation: Technology at the Neural Interface 22 (4), 484-488, 2019 | 40 | 2019 |
| Minority enrollment in Parkinson’s disease clinical trials: meta-analysis and systematic review of studies evaluating treatment of neuropsychiatric symptoms DG Di Luca, JA Sambursky, J Margolesky, JG Cordeiro, A Diaz, ... Journal of Parkinson's disease 10 (4), 1709-1716, 2020 | 21 | 2020 |
| Trends of inpatient palliative care use among hospitalized patients with Parkinson's disease DG Di Luca, M Feldman, S Jimsheleishvili, J Margolesky, JG Cordeiro, ... Parkinsonism & related disorders 77, 13-17, 2020 | 19 | 2020 |
| Sleep-related falling out of bed in Parkinson's disease DM Wallace, S Shafazand, DZ Carvalho, FB Nahab, C Sengun, A Russell, ... Journal of clinical neurology 8 (1), 51-57, 2012 | 18 | 2012 |
| Dancing dorsal quadrilaterals: a novel peripherally induced movement disorder KJ Lizarraga, PD Thompson, HP Moore, G Mizraji, OS Gershanik, ... JAMA neurology 76 (3), 351-354, 2019 | 15 | 2019 |
| Revisiting eligibility for deep brain stimulation: Do preoperative mood symptoms predict outcomes in Parkinson's disease patients? M Sarno, W Gaztanaga, N Banerjee, A Bure-Reyes, J Rooks, ... Parkinsonism & related disorders 63, 131-136, 2019 | 13 | 2019 |
| Management of motor features in advanced Parkinson Disease. H Moore, DS Shpiner, CC Luca Parkinson Disease, An Issue of Clinics in Geriatric Medicine E-Book …, 2019 | 10 | 2019 |
| Tandem gait abnormality in Parkinson disease: prevalence and implication as a predictor of fall risk J Margolesky, S Bette, DS Shpiner, EA Jordan, C Dong, T Rundek, ... Parkinsonism & related disorders 63, 83-87, 2019 | 9 | 2019 |
| Generalized chorea and JAK2V617F mutation‐positive myeloproliferative disorders S Betté, H Moore Movement Disorders Clinical Practice 7 (4), 462, 2020 | 7 | 2020 |
| OnabotulinumtoxinA dosing, disease severity, and treatment benefit in patients with cervical dystonia: a cohort analysis from CD PROBE P Agarwal, R Barbano, H Moore, M Schwartz, A Zuzek, M Sadeghi, ... Frontiers in neurology 13, 914486, 2022 | 5 | 2022 |
| Genome sequencing reveals novel noncoding variants in PLA2G6 and LMNB1 causing progressive neurologic disease N Borja, S Bivona, LS Peart, B Johnson, J Gonzalez, D Barbouth, ... Molecular genetics & genomic medicine 10 (4), e1892, 2022 | 5 | 2022 |
| Parkinson's disease HP Moore CRC Press, 2013 | 5 | 2013 |
